<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04248608</url>
  </required_header>
  <id_info>
    <org_study_id>AP1907-50101</org_study_id>
    <nct_id>NCT04248608</nct_id>
  </id_info>
  <brief_title>Perioperative Analgesic Modalities for Breast Cancer Surgeries</brief_title>
  <official_title>Perioperative Analgesic Modalities for Breast Cancer Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Institute, Egypt</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute, Egypt</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The incidence of breast cancer is among women world wide, detection increased with
      introduction of mammography as a screening tool. surgical resection of breast cancer
      contributes to the generation of acute and chronic post mastectomy pain. This study aims at
      comparing the effect of erector spinae block versus serratus block versus intravenous
      morphine in patients undergoing modified radical mastectomy for breast cancer surgeries
      regarding pain control and possible side effects
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One of the most common types of cancer affecting women is breast cancer. Surgical resection
      is one of the main approaches applied for solid tumors. surgical approach for breast cancer
      involve the breast region. Various analgesic modalities are used for proper perioperative
      pain control. Morphine has always been considered as the gold standard analgesic, however
      opioids have multiple side effects. Several loco-regional techniques have been introduced for
      breast surgery pain management including serratus plane block (SPB) and erector spinae plane
      (ESP) block. In this study the investigators are comparing the effect of erector spinae block
      versus serratus block versus intravenous morphine in patients undergoing modified radical
      mastectomy for breast cancer surgeries regarding intraoperative and postoperative analgesia,
      time to first analgesic, any possible side effects
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 28, 2020</start_date>
  <completion_date type="Actual">July 1, 2020</completion_date>
  <primary_completion_date type="Actual">July 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analogue score</measure>
    <time_frame>24 hours</time_frame>
    <description>minimum score (0), maximum score (10) maximum score (10)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total morphine consumption</measure>
    <time_frame>24 hours</time_frame>
    <description>total morphine in mg received in first 24 hours postoprative</description>
  </primary_outcome>
  <primary_outcome>
    <measure>First time to receive morphine</measure>
    <time_frame>24 hours</time_frame>
    <description>first time to receive morphine in the postoperative period (first 24 hours)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>mean arterial blood pressure</measure>
    <time_frame>24 hours</time_frame>
    <description>hemodynamic parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>heart rate</measure>
    <time_frame>24 hours</time_frame>
    <description>hemodynamic parameters</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>erector spinae block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultrasound guided erector spinae block with will be done after induction of intravenous anesthesia. After identification of trapezius, rhomboid major, and erector spinae muscles. The needle will be inserted in a cephalad-to-caudal direction until the tip contact transverse process and the needle tip is visualized in the plane deep to the erector spinae muscle. The needle tip position is confirmed by visualizing linear spread of test dose between the muscles after injection. A total dose of 25 mL of 0.25% bupivacaine will be injected.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>serratus anterior block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultrasound guided serratus anterior block will be done after induction of intravenous anesthesia. The serratus anterior, latissimus dorsi, and the intercostal muscles will be identified in the fourth and fifth intercostal level, an 18 G Tuohy needle will be advanced in the plane between the serratus anterior muscle and the intercostal muscles. A total dose of bupivacaine 25ml in a concentration of 0.25% will be administered under the serratus muscle after a test dose using an in-plane technique.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intravenous morphine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intravenous morphine will be administrated in a dose of 0.1 mg per kg after induction of general anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>serratus plane block</intervention_name>
    <description>ultrasound guided block</description>
    <arm_group_label>serratus anterior block</arm_group_label>
    <other_name>SAPB</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>erector spinae block</intervention_name>
    <description>ultrasound guided block</description>
    <arm_group_label>erector spinae block</arm_group_label>
    <other_name>ESPB</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Morphine Sulfate</intervention_name>
    <description>intravenous morphine sulfate 0.1 mg/kg</description>
    <arm_group_label>intravenous morphine</arm_group_label>
    <other_name>opioid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  female 18-65 years old patients undergoing modified radical mastectomy

        Exclusion Criteria:

          -  patient refusal, local infection at site of block coagulation defect abnormal kidney
             or liver functions
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>walaa Y Elsabeeny, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lecturer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of anesthesia and pain medicine. National Cancer Institute</name>
      <address>
        <city>Cairo</city>
        <zip>11796</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>January 22, 2020</study_first_submitted>
  <study_first_submitted_qc>January 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 30, 2020</study_first_posted>
  <last_update_submitted>July 18, 2020</last_update_submitted>
  <last_update_submitted_qc>July 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Institute, Egypt</investigator_affiliation>
    <investigator_full_name>Walaa Youssef Elsabeeny</investigator_full_name>
    <investigator_title>lecturer of anesthesia and pain management</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

